Curaleaf Holdings, Inc. Logo

Curaleaf Holdings, Inc.

CURLF

(1.2)
Stock Price

1,49 USD

-19.45% ROA

-20.19% ROE

-8.65x PER

Market Cap.

2.204.962.158,00 USD

60.1% DER

0% Yield

-14.85% NPM

Curaleaf Holdings, Inc. Stock Analysis

Curaleaf Holdings, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Curaleaf Holdings, Inc. Fundamental Stock Analysis
# Analysis Rating
1 Revenue Growth

With continuous growth in revenue over the last five years, this company has proven to be a lucrative investment option, showcasing its strong financial performance.

2 PBV

The stock's PBV ratio (2.21x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

3 DER

The stock has a reasonable amount of debt compared to its ownership (74%), suggesting a balanced financial position and a moderate level of risk.

4 Graham Number

The company's Graham number indicates that it is undervalued compared to its stock price, suggesting a potentially favorable investment opportunity.

5 ROE

Negative ROE (-33.29%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

6 ROA

The stock's ROA (-31.74%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

7 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

8 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

10 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

11 Buffet Intrinsic Value

The company's stock appears overvalued (-17) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Curaleaf Holdings, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Curaleaf Holdings, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

Curaleaf Holdings, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Curaleaf Holdings, Inc. Revenue
Year Revenue Growth
2014 0
2015 0 0%
2016 3.708.000 100%
2017 19.313.000 80.8%
2018 77.057.000 74.94%
2019 221.018.000 65.14%
2020 626.637.000 64.73%
2021 1.209.661.000 48.2%
2022 1.336.342.000 9.48%
2023 1.332.688.000 -0.27%
2023 1.371.327.635 2.82%
2024 1.368.861.632 -0.18%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Curaleaf Holdings, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2014 0
2015 0 0%
2016 26.759 100%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Curaleaf Holdings, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2014 45.330
2015 159.348 71.55%
2016 91.422 -74.3%
2017 17.390.000 99.47%
2018 63.277.000 72.52%
2019 125.441.000 49.56%
2020 234.881.000 46.59%
2021 373.897.000 37.18%
2022 430.946.000 13.24%
2023 363.644.000 -18.51%
2023 392.791.000 7.42%
2024 411.500.000 4.55%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Curaleaf Holdings, Inc. EBITDA
Year EBITDA Growth
2014 -47.025
2015 -161.380 70.86%
2016 -118.182 -36.55%
2017 430.000 127.48%
2018 -40.272.000 101.07%
2019 16.170.000 349.05%
2020 160.053.000 89.9%
2021 309.760.000 48.33%
2022 166.225.000 -86.35%
2023 261.624.000 36.46%
2023 259.469.675 -0.83%
2024 255.163.360 -1.69%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Curaleaf Holdings, Inc. Gross Profit
Year Gross Profit Growth
2014 0
2015 0 0%
2016 3.708.000 100%
2017 15.597.000 76.23%
2018 46.287.000 66.3%
2019 141.613.000 67.31%
2020 390.513.000 63.74%
2021 687.589.000 43.21%
2022 579.031.000 -18.75%
2023 600.208.000 3.53%
2023 486.425.829 -23.39%
2024 495.485.792 1.83%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Curaleaf Holdings, Inc. Net Profit
Year Net Profit Growth
2014 -46.017
2015 -160.782 71.38%
2016 -118.182 -36.05%
2017 -5.044.000 97.66%
2018 -61.877.000 91.85%
2019 -69.848.000 11.41%
2020 -61.328.000 -13.89%
2021 -109.130.000 43.8%
2022 -376.931.000 71.05%
2023 -369.388.000 -2.04%
2023 -286.353.819 -29%
2024 -195.499.672 -46.47%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Curaleaf Holdings, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2014 0
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 -1 0%
2023 -1 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Curaleaf Holdings, Inc. Free Cashflow
Year Free Cashflow Growth
2014 -34.184
2015 -162.537 78.97%
2016 -107.476 -51.23%
2017 -18.455.000 99.42%
2018 -78.960.000 76.63%
2019 -120.396.000 34.42%
2020 -113.918.000 -5.69%
2021 -205.919.000 44.68%
2022 -91.961.000 -123.92%
2023 5.048.924 1921.4%
2023 29.642.000 82.97%
2024 4.608.994 -543.13%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Curaleaf Holdings, Inc. Operating Cashflow
Year Operating Cashflow Growth
2014 -24.838
2015 -153.878 83.86%
2016 -106.886 -43.97%
2017 -7.715.000 98.61%
2018 -33.101.000 76.69%
2019 -38.321.000 13.62%
2020 12.355.000 410.17%
2021 -33.964.000 136.38%
2022 46.401.000 173.2%
2023 76.641.197 39.46%
2023 45.349.000 -69%
2024 29.476.695 -53.85%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Curaleaf Holdings, Inc. Capital Expenditure
Year Capital Expenditure Growth
2014 9.347
2015 8.659 -7.95%
2016 590 -1369.95%
2017 10.740.000 99.99%
2018 45.859.000 76.58%
2019 82.075.000 44.13%
2020 126.273.000 35%
2021 171.955.000 26.57%
2022 138.362.000 -24.28%
2023 71.592.273 -93.26%
2023 15.707.000 -355.8%
2024 24.867.701 36.84%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Curaleaf Holdings, Inc. Equity
Year Equity Growth
2014 72.860
2015 143.025 49.06%
2016 36.178 -295.34%
2017 104.765.000 99.97%
2018 435.642.000 75.95%
2019 403.446.000 -7.98%
2020 1.376.214.000 70.68%
2021 1.808.490.000 23.9%
2022 1.400.817.000 -29.1%
2023 1.211.996.000 -15.58%
2023 1.165.299.318 -4.01%
2024 1.107.011.626 -5.27%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Curaleaf Holdings, Inc. Assets
Year Assets Growth
2014 82.037
2015 151.698 45.92%
2016 47.683 -218.14%
2017 151.602.000 99.97%
2018 569.836.000 73.4%
2019 736.926.000 22.67%
2020 2.386.591.000 69.12%
2021 3.262.478.000 26.85%
2022 3.397.919.000 3.99%
2023 3.226.473.000 -5.31%
2023 3.080.732.988 -4.73%
2024 3.082.499.869 0.06%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Curaleaf Holdings, Inc. Liabilities
Year Liabilities Growth
2014 9.177
2015 8.673 -5.81%
2016 11.505 24.62%
2017 46.837.000 99.98%
2018 134.194.000 65.1%
2019 333.480.000 59.76%
2020 1.010.377.000 66.99%
2021 1.453.988.000 30.51%
2022 1.997.102.000 27.2%
2023 2.014.477.000 0.86%
2023 1.915.433.669 -5.17%
2024 1.975.488.242 3.04%

Curaleaf Holdings, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
1.85
Net Income per Share
-0.34
Price to Earning Ratio
-8.65x
Price To Sales Ratio
1.61x
POCF Ratio
18.2
PFCF Ratio
52.37
Price to Book Ratio
2.22
EV to Sales
2.33
EV Over EBITDA
11.77
EV to Operating CashFlow
26.32
EV to FreeCashFlow
75.58
Earnings Yield
-0.12
FreeCashFlow Yield
0.02
Market Cap
2,20 Bil.
Enterprise Value
3,18 Bil.
Graham Number
3.22
Graham NetNet
-2.32

Income Statement Metrics

Net Income per Share
-0.34
Income Quality
-0.56
ROE
-0.25
Return On Assets
-0.07
Return On Capital Employed
0.02
Net Income per EBT
1.97
EBT Per Ebit
-2.35
Ebit per Revenue
0.03
Effective Tax Rate
-0.98

Margins

Sales, General, & Administrative to Revenue
0.28
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.02
Gross Profit Margin
0.39
Operating Profit Margin
0.03
Pretax Profit Margin
-0.08
Net Profit Margin
-0.15

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.16
Free CashFlow per Share
0.06
Capex to Operating CashFlow
0.65
Capex to Revenue
0.06
Capex to Depreciation
0.36
Return on Invested Capital
0.06
Return on Tangible Assets
-0.19
Days Sales Outstanding
18.47
Days Payables Outstanding
43.84
Days of Inventory on Hand
98.37
Receivables Turnover
19.76
Payables Turnover
8.33
Inventory Turnover
3.71
Capex per Share
0.11

Balance Sheet

Cash per Share
0,12
Book Value per Share
1,49
Tangible Book Value per Share
-0.9
Shareholders Equity per Share
1.34
Interest Debt per Share
0.95
Debt to Equity
0.6
Debt to Assets
0.19
Net Debt to EBITDA
3.61
Current Ratio
1.09
Tangible Asset Value
-0,67 Bil.
Net Current Asset Value
-1,55 Bil.
Invested Capital
2649208765
Working Capital
0,03 Bil.
Intangibles to Total Assets
0.58
Average Receivables
0,07 Bil.
Average Payables
0,09 Bil.
Average Inventory
223678353.5
Debt to Market Cap
0.27

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Curaleaf Holdings, Inc. Dividends
Year Dividends Growth

Curaleaf Holdings, Inc. Profile

About Curaleaf Holdings, Inc.

Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates in two segments, Cannabis Operations and Non-Cannabis Operations. The Cannabis Operations segment engages in the production and sale of cannabis through retail and wholesale channels. The Non-Cannabis Operations segment provides professional services, including cultivation, processing, and retail know-how and back-office administration, intellectual property licensing, real estate leasing services, and lending facilities to medical and adult-use cannabis licensees under management service agreements. It offers flowers, pre-rolls, flower pods, and dry-herb vaporizer cartridges; concentrates for vaporizing, such as pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, including distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. The company also provides hemp-based CBD products. As of June 16, 2022, it operated 134 dispensaries and 26 cultivation sites in 22 states of the United States. The company was founded in 2010 and is headquartered in Wakefield, Massachusetts.

CEO
Mr. Boris Alexis Jordan
Employee
5.650
Address
301 Edgewater Place
Wakefield, 01880

Curaleaf Holdings, Inc. Executives & BODs

Curaleaf Holdings, Inc. Executives & BODs
# Name Age
1 Mr. Peter Laurence Clateman J.D.
Chief Legal Officer
70
2 Mr. Edward Kremer
Chief Financial Officer
70
3 Mr. James S. Shorris
Chief Compliance Officer
70
4 Mr. Jakob Feinstein
Manager of Investor Relations
70
5 Mr. Camilo Russi Lyon
Chief Investment Officer
70
6 Mr. Boris Alexis Jordan
Chief Executive Officer & Chairman
70
7 Mr. Joseph F. Lusardi
Executive Vice-Chairman
70
8 Mr. Scott Baughman
Chief Technology Officer
70
9 Mr. Matthew S. Darin
Special Advisor
70
10 Ms. Christine Taylor
Chief Accounting Officer
70

Curaleaf Holdings, Inc. Competitors

Cresco Labs Inc. Logo
Cresco Labs Inc.

CRLBF

(1.2)
Cronos Group Inc. Logo
Cronos Group Inc.

CRON

(2.2)
HEXO Corp. Logo
HEXO Corp.

HEXO

(0.8)